Calamos Autocallable Income (CAIE) ETF Holdings & Analysis
ETFOther
What CAIE does
The Calamos Autocallable Income ETF aims to provide investors with substantial monthly payouts while mitigating potential market downturns, achieved through its strategic investment in a diversified collection of autocallable instruments.
Fund profile
Top holdings
| Holding | Weight | |
|---|---|---|
| TRS RECEIVE MQAUTOCL: MerQube US Large-Cap Vol Adv Autocallable PAY US SOFR Rate +10bps - JP Morgan | 49.33% | |
| Calamos Tax-Aware Collateral ETF | 42.57% | |
| United States Treasury Bill | 6.91% | |
| NET OTHER ASSETS | 0.64% | |
| US DOLLAR | 0.55% |
Sector allocation
| Cash & Others | 100.00% |
Geographic allocation
| Other | 100.00% |
PortView Portfolio Insights
PortView analyzes how CAIE fits your actual portfolio — position weight, ETF overlap with your other funds, sector and geographic exposure, concentration, and how this fund contributes to your portfolio risk and return. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze CAIE in PortView →Related securities
Related stocks
Frequently asked questions
- What does CAIE track?
- CAIE is the Calamos Autocallable Income ETF, a Other ETF.
- What is the expense ratio of CAIE?
- Expense ratio data for CAIE is shown on the page when available from our data provider.
- What are the largest holdings in CAIE?
- Top holdings include TRS RECEIVE MQAUTOCL: MerQube US Large-Cap Vol Adv Autocallable PAY US SOFR Rate +10bps - JP Morgan, Calamos Tax-Aware Collateral ETF, United States Treasury Bill, NET OTHER ASSETS, US DOLLAR.
- How can PortView analyze CAIE overlap with other ETFs?
- PortView computes the holdings overlap between CAIE and the other ETFs and stocks you own, plus your combined sector and geographic exposure, so you can see true diversification.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.